Cáncer de pulmón microcítico: revisión

  • Carmen Guillén
  • María José Molina

Abstract

Twenty percent of all lung cancers are of small cells (CPCP). More than half occur to people aged 60 and more. Due to its fast dissemination, most of them show symptoms when diagnosed (90%). These symptoms can be derived from its locoregional extension, metastases or can have a paraneoplastical origin. Anamnesis and thorough physical exploration are essential for the initial evaluation and adequate treatment. In addition to a blood analysis with determination of enzymes such as lactate dehydrogenase which helps in prognosis, thorax and abdominal computed tomography (CT), bone gammagraphy and cerebral CT or magnetic resonance imaging (MRI) allow optimum estadification. Although CPCP is chemo- and radio-sensitive, small progress has been achieved in the last years and its mortality rate is high. The objective of this paper is to revise all these aspects related to CPCP.

Downloads

Download data is not yet available.

Article download

Crossmark

Metrics

Published
2006-01-01
How to Cite
Guillén C. . y Molina M. J. . (2006). Cáncer de pulmón microcítico: revisión. Psicooncología, 3(2), 249-267. https://revistas.ucm.es/index.php/PSIC/article/view/PSIC0606220249A
Issue
Vol 3, No 2-3 (2006)
Section
Articles

License

In order to support the global exchange of knowledge, the journal Psicooncología is allowing unrestricted access to its content as from its publication in this electronic edition, and as such it is an open-access journal. The originals published in this journal are the property of the Complutense University of Madrid and any reproduction thereof in full or in part must cite the source. All content is distributed under a Creative Commons Attribution 4.0 use and distribution licence (CC BY 4.0). This circumstance must be expressly stated in these terms where necessary. You can view the summary and the complete legal text of the licence.